M&A / Deals Merck buys life sciences firm Bio-Techne in $11.3bn deal PharmaphorumMerck KGaA is poised to increase the size of its life sciences business with an $11.3 billion deal to acquire rival Bio-techne.Read full story pharminent June 25, 2026 (Last updated: June 26, 2026) Pharmaphorum Merck KGaA is poised to increase the size of its life sciences business with an $11.3 billion deal to acquire rival Bio-techne. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Ionis secures market expansion for Tryngolza as FDA clears severe hypertriglyceridemia useNext: Ionis grants Recordati rights to zilganersen for Alexander disease Related Stories M&A / Deals Spero snaps up Innovent immunology drug in strategic pivot pharminent July 14, 2026 M&A / Deals AstraZeneca takes another China trip, picking Dizal’s lung cancer drug for up to $1.5B pharminent July 14, 2026 M&A / Deals Novartis and Chai Discovery collaborate on antibody identification pharminent July 14, 2026
